Clinical Trial Update: A Study of Single and Multiple Doses of Different Formulations of a Prostacyclin Receptor Agonist [Phase 1]

View source ↗

Summary

Phase 1 trial update reporting completion of single- and multiple-dose assessments of different formulations of a prostacyclin receptor agonist for pulmonary ar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Uptravi (selexipag)

Snippet

Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 1 | Status: COMPLETED